3D cell culture systems have recently as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM). Join us for this webinar to know more about BIOMIMESYS® technology, our 3D cell culture system designed for the physiologically-relevant culture of liver, brain, adipose tissue, and cancer cells in dedicated BIOMIMESYS® hydroscaffolds. Each matrix is characterized by its specific composition and stiffness, to be in accordance with in vivo conditions.
Grégory MAUBON
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.
1 Comment
In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology – HCS Pharma · March 23, 2021 at 2:14 pm
[…] BIOMIMESYS®-based in vitro results better correlate with in vivo results. For more information, see the presentation webinar. […]